| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 07/25/2002 | WO2002056804A2 Presbyopia treatment by lens alteration |
| 07/25/2002 | WO2001074346A3 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 07/25/2002 | WO2001062289B1 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 07/25/2002 | US20020099357 Ocular iontophoretic device and method for using the same |
| 07/25/2002 | US20020099322 Adhering therapeutic tool |
| 07/25/2002 | US20020099308 Fluid collection and monitoring device |
| 07/25/2002 | US20020099094 Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris |
| 07/25/2002 | US20020098469 Extracorporeal methods for enhancing antigen presentation and immune responsiveness |
| 07/25/2002 | US20020098252 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/25/2002 | CA2435374A1 Presbyopia treatment by reducing and preventing lenticular disulfide crosslinks |
| 07/24/2002 | EP1225169A1 Radiation-activated cytotoxin therapy |
| 07/24/2002 | EP1224461A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/24/2002 | EP1223982A2 Conjugate for treating atheroma and other diseases |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223952A2 Methods for treatment of solid tumors and metastasis by gene therapy |
| 07/24/2002 | EP0821593B1 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
| 07/23/2002 | US6423547 Non-covalent bioconjugates useful for diagnosis and therapy |
| 07/23/2002 | CA2256348C Method of improving skin condition |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055027A2 Placebo effect and relaxation response |
| 07/18/2002 | WO2002003800A9 Device and method for photoactivated drug therapy |
| 07/18/2002 | WO2001095936A3 Monoterpenes and sesquiterpenes as radiation sensitizers |
| 07/18/2002 | US20020094998 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 07/17/2002 | EP1221974A2 Magnetic targeted carrier |
| 07/17/2002 | EP1221946A2 Targeted drug activation |
| 07/16/2002 | US6421361 Tunable diode laser system for photodynamic therapy |
| 07/16/2002 | US6420570 Psoralen compounds |
| 07/16/2002 | US6419897 Porphyrin compounds |
| 07/12/2002 | CA2330995A1 Toluidine blue-based photodynamic therapy for inducing apoptosis in activated t-lymphocytes, and consequently for treating psoriasis and for bone marrow purging |
| 07/11/2002 | WO2001074389A3 Improved treatment of neovascularization |
| 07/11/2002 | WO2001030397A3 Ultrasound inducement of artial and ventricular rhythms |
| 07/11/2002 | WO2000049937A9 Trpm-2 antisense therapy |
| 07/11/2002 | US20020091424 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and benzalkonium chloride |
| 07/11/2002 | US20020091311 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 07/11/2002 | US20020090359 Transforming growth factor regulation |
| 07/11/2002 | US20020090358 Chronic lymphocytic leukemia treatment |
| 07/11/2002 | US20020090340 B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 07/09/2002 | US6416740 Acoustically active drug delivery systems |
| 07/04/2002 | WO2002000870A3 Method for transfecting cells using a magnetic field |
| 07/04/2002 | WO2001036007A3 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 07/04/2002 | US20020087205 Transcutaneous photodynamic treatment of targeted cells |
| 07/04/2002 | US20020086814 Selectively killing cells via targeting fragment of a toxin or lectin with photosensitizing agent, then exposing to light/radiation |
| 07/04/2002 | DE10065482A1 New heavier halogen atom substituted squarane dyes, used as photosensitizer in photodynamic therapeutical applications, fluorescent detector of tumors and sensitizer in water sterilization |
| 07/03/2002 | EP1218032A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/03/2002 | EP1100366A4 Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea |
| 07/03/2002 | CN1356892A Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
| 07/02/2002 | US6413714 Process for the sterilization of biological compositions and the product produced thereby |
| 06/27/2002 | WO2002049714A2 Electrically responsive promoter system |
| 06/27/2002 | WO2002049669A2 Electrically responsive promoter system |
| 06/27/2002 | WO2002049635A2 Use of 5-aminolevulinic acid for the prophylaxis of restenosis |
| 06/27/2002 | WO2001012217A9 Therapeutic antibody against muc-1 antigen and methods for their use |
| 06/27/2002 | US20020082527 Assessment and control of acoustic tissue effects |
| 06/27/2002 | DE10063076A1 Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe Use of 5-aminolevulinic acid for restenosis prophylaxis |
| 06/27/2002 | CA2432310A1 Electrically responsive promoter system |
| 06/26/2002 | EP1037531A4 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 06/25/2002 | US6409719 Light stint implant device for treatment of long term viral infection |
| 06/20/2002 | WO2000056774A9 Methods of using bioelastomers |
| 06/13/2002 | WO2002045724A2 Use of modified mammalian blood for treating transforming growth factor related diseases |
| 06/13/2002 | WO2001090159A3 Compositions and methods for delivery of a molecule into a cell |
| 06/13/2002 | WO2001082899A3 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 06/13/2002 | WO2001072721A3 Synergistic methods and compositions for treating cancer |
| 06/13/2002 | WO2001035997A3 Use of low-dose pdt to inhibit restenosis |
| 06/12/2002 | EP1212057A1 Extended duration light activated cancer therapy |
| 06/12/2002 | CN1353620A Cosmetic deilation kit with photosensitizer |
| 06/11/2002 | US6403056 Administering agent; applying ultrasonic frequency |
| 06/11/2002 | US6402037 Two-photon upconverting dyes and applications |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | WO2002000906A3 Replication deficient adenoviral tnf vector |
| 06/06/2002 | WO2001089576A3 Preparation hypericin bonded with poly-n-vinylamides |
| 06/06/2002 | US20020068747 Inhibitors of prenyl-protein transferase |
| 06/06/2002 | US20020068717 Methods and compositions for enhancing diffusion of therapeutic agents through tissue |
| 06/06/2002 | US20020068692 Administration a melatonin blocker to patients with disorders associated with altered dopamine function; preclinical diagnosis by administering melatonin to induce a mild transient form of the disorder |
| 06/06/2002 | US20020068267 Process for the sterilization of biological compositions and the product thereby |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/05/2002 | EP1210182A1 Permeabilizing biofilms |
| 06/05/2002 | EP1210148A2 Dosimetry for californium-252 brachytherapy sources and encapsulation, storage, and clinical delivery thereof |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | CA2327630A1 Transforming growth factor regulation |
| 05/30/2002 | WO2002041923A1 Preparation for curing oncological disease, method for producing and using said composition |
| 05/30/2002 | WO2001035867A8 Ophthalmologic implant |
| 05/30/2002 | US20020065467 Methods and apparatus for monitoring and quantifying the movement of fluid |
| 05/29/2002 | EP1208005A1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 05/29/2002 | EP0691841B1 Medicament dispensing stents |
| 05/28/2002 | US6397102 Fullerene complexes |
| 05/28/2002 | US6395257 Administering indocyanine dye of specific structure to individual for diagnostic imaging or antitumor therapy |
| 05/23/2002 | WO2002040639A2 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 05/23/2002 | WO2002040488A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy |
| 05/23/2002 | WO2002040093A2 Ablation of cells using combined electric field and ultrasound therapy |
| 05/23/2002 | WO2002040050A1 Non-lethal methods for conditioning a recipient for bone marrow transplantation |
| 05/23/2002 | WO2002039953A2 Texaphyrin coordination compounds and uses thereof |
| 05/23/2002 | US20020061900 Imidazo-isoquinolin-5-one derivatives, pyrimido-isoquinolin-6-one derivatives and imidazo-naphthyridin-5-one derivatives |
| 05/23/2002 | US20020061871 Photochemotherapeutic compositions |
| 05/23/2002 | US20020061330 Supports for photosensitizer formulations |
| 05/23/2002 | DE10104762A1 Method for transmitting beneficial effects of an essence to an organism involves production of a Kirlian color photograph of the essence and transmission of the image of this photograph through the essence |
| 05/23/2002 | CA2429411A1 Texaphyrin coordination compounds and uses thereof |
| 05/22/2002 | EP1206288A2 Targeted fiberless radiative effectors |
| 05/22/2002 | EP0745085B1 Texaphyrin metal complexes having improved functionalization |